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Assessing the feasibility and acceptability of 
community health extension workers to treat 
hypertension associated with pregnancy: An 
analysis of post-intervention findings
Pre-eclampsia/ Eclampsia 
(PE/E) IN BRIEF
• Pre-eclampsia is a condition in 
pregnant women marked by an 
increase in blood pressure and 
protein in urine after 20 weeks 
gestation.
• Providing high quality antenatal 
care improves the prevention and 
early detection of pre-eclampsia 
and can prevent its progression to 
eclampsia.
• Eclampsia is a life-threatening 
condition characterized by 
convulsions in women with PE.
• Women in developing countries 
are 300 times more likely to die 
from eclampsia than women in 
developed countries.
• Prescribing low-dose aspirin 
and calcium to at-risk women 
can prevent pre-eclampsia and 
eclampsia.
• Pre-eclampsia and eclampsia can 
be managed by administering 
anti-hypertensive drugs and 
magnesium sulphate (MgSO4).
• MgSO4 is the safest and most 
effective treatment for severe 
PE/E, and is one of 13 UN Life-
Saving Commodities for Women 
and Children.
• PE/E and other hypertensive 
disorders in pregnancy increase 
the risk of pre-term births, which 
can lead to low birth weight, 
anemia, and stunting.
• Improved prevention, increased 
detection, and effective treatment 
of PE/E can prevent unnecessary 
maternal and newborn deaths.
BACKGROUND
 In Nigeria, hypertensive disorders of pregnancy (HDPs) – mainly pre-eclampsia 
and eclampsia (PE/E) – are the most common causes of death in pregnant 
women, accounting for 23 percent of maternal deaths in tertiary health facilities. 
Uncon¬trolled hypertension puts women at risk of cerebrovascular accident, a 
common cause of death from PE/E. Averting deaths from PE/E requires early 
detection, timely delivery of the baby, effective use of antihypertensive drugs 
to control the associated hypertension, and administration of magnesium 
sulphate (MgSO4) to prevent and treat convulsions. 
Community Health Extension Workers (CHEWs) are authorized to administer 
the loading of MgSO4 prior to referring a pregnant woman with PE/E to a 
secondary or tertiary health facility. Nigeria’s task shifting policy is unclear 
on whether CHEWs – often the first points of contact for pregnant women 
– are permitted to administer antihypertensive drugs to pregnant women. 
There is a need, therefore, to determine whether CHEWs can safely administer 
antihypertensive drugs for HDPs.
RESEARCH AIM
This study tested the feasibility of tasking CHEWs with detecting and 
managing  hypertension, and prescribing an oral antihypertensive drug – 
alpha methyldopa (aldomet) – at primary health care (PHC) facilities as 
part of a package of care for women with PE/E. This evaluation measured 
improve¬ments in knowledge retention and increases in early detection, 
prevention, and management of PE/E.
INTERVENTION
In Ebonyi State, 43 CHEWs in 20 intervention PHCs received training (theory) 
and mentoring (skills) on accurate measurement of blood pressure (BP) in 
pregnant women and categorization as normal, mild, moderate, or severe 
hypertension, as well as how to manage hypertension using oral alpha 
methyldopa. 
CHEWs in the intervention facilities prescribed and dispensed alpha 
methyldopa to women with moderate and se-vere hypertension. If the drug was 
not available at the facility, women and their families may have had to obtain 
the drug at outside, local pharmacies. CHEWs then asked women to return 
to the PHC for refills and BP measurement every month during pregnancy. 
If hypertension was not controlled, women were referred to a hospital. In an 
impending case of severe PE/E, the woman received the loading dose of 
MgSO4 according to national policy and was referred to a secondary facility for 
further management.
Twenty-nine CHEWs in 20 comparison facilities did not prescribe alpha 
methyldopa, but instead were expected to refer pregnant women with moderate 
or high BP to referral hospitals. Any available physicians in comparison 
facilities could dispense and prescribe antihypertensive drugs, based on their 
clinical judgment to best address the woman’s condition. 
The Ending Eclampsia project seeks to expand access 
to proven,underutilized interventions and commodities 
for the prevention, early detection, and treatment of 




CHEWs’ Knowledge Retention 
Trained CHEWs working at intervention PHCs can 
correctly identify, differentiate, and manage normal, 
mild, moderate, and severe hypertension. At baseline, 
only 4% of intervention providers could correctly 
identify hypertension as normal, mild, moderate, or 
severe, but at endline 67% could correctly differentiate. 
Overall, intervention providers were 60% more likely to 
correctly identify hypertension than the comparison 
group (p<.001). Following training, 75% providers 
could correctly describe how to manage hypertension, 
compared to only 40% at baseline (p<0.001); comparison 
group providers saw a decrease in knowledge retention of 
hypertension management from 38% to 16% (p<0.001). 
There was 55% improvement in knowledge of proper 
timing for administration of a MgSO4 loading dose among 
trained providers, whereas comparison provider MgSO4 
knowledge at endline improved by only 14% (p=0.021). 
Figure 1 below describes changes in CHEW’s knowledge 
of HDPs pre- and post-intervention. 
CHEWs’ Knowledge of Treating Hypertension
Ninety-two percent of CHEWs in intervention facilities 
identified alpha methyldopa as a drug used to control 
BP at endline, compared to 14% at baseline. Overall, 
CHEWs in the intervention group were 36% more likely 
to name alpha methyldopa as a drug used to control 
blood pressure than CHEWs in the comparison group 
(p=.019). In the intervention and control groups, 
CHEWs were more likely to prescribe alpha methyldopa 
over other antihypertensive drugs (60% and 50% 
of providers, respectively). Interestingly, theoretical 
knowledge of antihypertensives and actual practice 
do not always align and require sustained oversight 
and mentorship. For example, though almost no 
CHEWs in either the intervention or comparison groups 
spontaneously named Labetalol as a drug that controls 
blood pressure, in practice, it was the second most-
prescribed antihypertensive drug after alpha methyldopa 
among CHEWs in the intervention group at endline 
(34.3% of providers named it as the most prescribed 
antihypertensive at their facility).
CHEWs’ Ability to Diagnose & Treat Hypertension
Following training, only one patient seen by the intervention 
providers was incorrectly diagnosed, while one woman 
was correctly diagnosed with PE, 15 with severe PE, and 
23 with another HDP. Comparison providers incorrectly 
diagnosed nine women, but correctly diagnosed one 
woman with PE and four women with other HDPs. 
Among women with moderate-to-severe hypertension 
who required antihypertensive drugs upon diagnosis, 
89% of women in the intervention PHCs received 
treatment, compared to only 20% in the comparison 
PHCs. Furthermore, 50% of women with severe PE in 
the intervention PHCs received a loading dose of MgSO4 
at diagnosis, but no women in the comparison PHCs 
received the loading dose. Most PHCs in intervention and 
comparison groups procure antihypertensive drugs from 
facility arrangements within the open market (92% and 
57%, respectively). CHEWs from both groups reported 
that procurement cost is the greatest barrier to stocking 
antihypertensive drugs.  
Between July 2016 and December 2017, 54 pregnant 
women from Ebonyi State who presented with high BP 
were monitored and followed up until after delivery. See 
Table 1 for client details. Gestational age at point of first 
contact with PHCs shows that no women in our sample 
sought ANC prior to 12 weeks of pregnancy and many 
waited until close to their third trimester, suggesting 
normalized delays maternal care-seeking.
Maternal & Fetal Health Outcomes 
Throughout the duration of this study, there were five 
maternal deaths – one in the intervention group and 
four in the comparison group. Thirteen fetal deaths 
occurred, four in the intervention group and nine in the 
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Figure 1: CHEWs’ pre- and post-intervention knowledge of hypertensive disorders in pregnancy
comparison group. All maternal deaths occurred among 
women who did not receive MgSO4. To better understand 
barriers that lead to these deaths, further analysis of the 
timing of severe PE/E diagnosis and reasons for delay in 
administering the loading dose is needed.
DISCUSSION
Findings from this study to task-shift PE/E detection 
and management to CHEWs are encouraging. Overall, 
PHC providers are able to distinguish mild, moderate, 
and severe hypertension in pregnant women and 
diagnose PE/E at PHCs. Improvements among CHEWs 
who received intensive training, as well as differences 
between intervention and comparison CHEWs, indicate 
that HDPs and PE/E can be detected and managed 
at the PHC level. Challenges continue when ensuring 
women have access to care early in their pregnancies. As 
mentioned, appropriate PE/E management requires early 
detection, but the majority of women came to their first 
ANC appointment (booking appointment) once high BP 
had occurred and they felt unwell. 
A national task-shifting policy exists in Nigeria, and these 
findings are important contributions to implementing the 
national policy at the local level. Training and mentoring 
CHEWs to detect and manage PE/E at the local level 
will improve access to life-saving care for women, their 
families, and their communities, and will contribute to 
stronger health systems and improved maternal health 
outcomes in Nigeria.
RECOMMENDATIONS
• Sustain CHEW training, mentoring, and oversight, as 
needed for the detection and management of HDPs;
• Streamline state procurement for supplies and 
commodities, and enhance linkages to central 
distribution system of antihypertensive drugs and 
MgSO4;
• Amend national task-shifting policy to explicitly 
include antihypertensive drug administration at the 
PHC level;
• Scale up task-shifting for antihypertensive drug use 
at PHC level across Nigeria; and
• Conduct further analysis to understand women’s 
maternal health-seeking behavior.
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Table 1: Characteristics of pregnant women at first and follow up ANC visits
Women’s Characteristics Intervention PHCs, n=40 (%) Comparison PHCs, n=14 (%) Total, n=54 (%)
Age                                                           15-24 9 (22.5) 5 (35.7) 14 (25.9)
25-34 19 (47.5) 4 (28.6) 23 (42.6)
>35 12 (30) 5 (35.7) 17 (31.5)
Education                         No formal education 7 (17.5) 1 (7.7) 8 (15.1)
Primary 11 (27.5) 4 (30.8) 15 (28.3)
Secondary 19 (47.5) 8 (61.6) 27 (50.9)
First degree 3 (7.5) 0 3 (5.6)
BP at ANC booking                <140/90 mmhg 14 (35) 10 (71.4) 24 (44.4)
>140/90 mmhg 21 (52.5) 2 (14.3) 23 (42.6)
Unrecorded 5 (12.5) 2 (14.3) 7 (13)
Proteinuria at ANC booking                         +1 0 0 0
+2 2 (10) 0 4 (7.4)
>+3 5 (12.5) 0 5 (9.3)
Nil/ trace 31 (77.5) 14 (100) 45 (83.3)
Gestation at ANC booking             <12 weeks 0 0 0
12-20 weeks 13 (32.5) 5 (35.7) 18 (33.3)
21-30 weeks 11 (27.5) 4 (28.6) 15 (28)
31-40 weeks 10 (25) 2 (14.3) 12 (19.7)
Gestation at HDP diagnosis           <12 weeks 0 0 0
12-20 weeks 6 (15) 3 (21.4) 9 (16.7)
21-30 weeks 15 (37.5) 4 (28.5) 19 (35.2)
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